Magnetic resonance imaging for long‐term active surveillance biopsy decision‐making
An unsuspicious MRI at 6 years is not enough alone to omit the 6-year AS biopsy under current guidelines. Combining MRI findings, PSA density, and prior negative AS biopsies is a promising strategy to tailor surveillance intensity. Our findings should be replicated in larger cohorts prior to implementation in clinical practice.
Authors
- Andrew Julian Vickers (ORCID: https://orcid.org/0000-0003-1525-6503)
- Amy L. Tin (ORCID: https://orcid.org/0000-0002-8005-0694)
- Francesco Montorsi (ORCID: https://orcid.org/0000-0002-7267-4181)
- Behfar Ehdaie (ORCID: https://orcid.org/0000-0003-2949-0632)
- Riccardo Leni (ORCID: https://orcid.org/0000-0003-0779-0984)
- Oğuz Akın (ORCID: https://orcid.org/0000-0002-2041-6199)
- Sigrid Carlsson (ORCID: https://orcid.org/0000-0003-3553-5710)
- Nicole Liso
- James A. Eastham
- Alberto Briganti
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Vita-Salute San Raffaele University (IT)
- Lund University (SE)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- University of Gothenburg (SE)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1111/bju.16798
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Memorial Sloan-Kettering Cancer Center
- National Cancer Institute